T1	Participants 246 289	high-risk patients with long-bone fractures
T2	Participants 410 474	corticosteroid- (0 of 21) and placebo-treated patients (9 of 41)
T3	Participants 1033 1084	patients at high risk for the fat embolism syndrome
T4	Participants 805 846	all patients studied who had the syndrome
